AbbVie Says Suit Over Nixed $54B Shire Merger Should End
Biopharmaceutical company AbbVie Inc. said Tuesday that an absence of specific claims should shut down a stockholder suit seeking damages for the company from directors in the wake of AbbVie's 2014...To view the full article, register now.
Already a subscriber? Click here to view full article